Mankind Pharma plans Russia subsidiary, CSR arm, integration committee

Mankind Pharma (BSE: 543904) announced significant strategic moves following its board meeting on April 14, 2025, including the formation of a "Structural Integration Committee" to evaluate integrating Bharat Serums and Vaccines Limited ("BSV") into Mankind Pharma’s ecosystem. The board will review a concrete integration plan in the coming months after consultation with financial, legal, and tax advisors, pending necessary approvals.